Literature DB >> 21470384

A change in treatment from etanercept to infliximab was effective to control scleritis in a patient with rheumatoid arthritis.

Yukio Sassa, Yo-Ichi Kawano, Toshiko Yamana, Tatsuoki Mashima, Tatsuro Ishibashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21470384     DOI： 10.1111/j.1755-3768.2010.02090.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  4 in total

Review 1.  Biologic therapy for refractory scleritis: a new treatment perspective.

Authors:  Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal:  Int Ophthalmol       Date:  2015-08-29       Impact factor: 2.031

2.  Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy.

Authors:  Sara Benchérifa; Bouchra Amine; Imane El Binoune; Samira Rostom; Rachid Bahiri
Journal:  BMC Rheumatol       Date:  2020-02-07

Review 3.  Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives.

Authors:  Veronique Promelle; Vincent Goeb; Julie Gueudry
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

Review 4.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.